S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in
NASDAQ:NSTG

NanoString Technologies Stock Forecast, Price & News

$69.79
-0.85 (-1.20 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$67.67
Now: $69.79
$74.70
50-Day Range
$63.59
MA: $74.29
$82.96
52-Week Range
$13.85
Now: $69.79
$86.42
Volume633,540 shs
Average Volume639,504 shs
Market Capitalization$3.08 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.77
NanoString Technologies, Inc. provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and pan cancer and 360 gene expression, CAR-T characterization, neuropathology and neuro-inflammation gene expression, autoimmune disease gene expression, miRNA expression, human organ transplant, human and mouse metabolic pathway, and human and mouse fibrosis panels. Further, the company offers nCounter based reagents that allow users to design customized assays; Master Kits, such as ancillary reagents and plasticware to setup and process samples in the nCounter Prep Station and nCounter Digital Analyzer; and Prosigna molecular diagnostic test kits. The company is also developing GeoMx DSP system to enable the field of spatial genomics; and Hyb & Seq molecular profiling system to determine and analyze gene sequences within biological samples. It has collaboration with Celgene Corporation; Merck & Co., Inc.; Medivation, Inc.; Astellas Pharma, Inc.; and Oregon Health & Science University for the development of novel GeoMx® Digital Spatial Profiler protein assays to spatially profile breast cancer. NanoString Technologies, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
NanoString Technologies logo

Headlines

A Preview Of NanoString Technologies's Earnings
February 26, 2021 |  benzinga.com
Is NSTG A Good Stock To Buy Now?
December 18, 2020 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry Biological products, except diagnostic
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NSTG
CUSIPN/A
Phone206-378-6266
Employees551
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$125.57 million
Book Value$2.91 per share

Profitability

Net Income$-40,700,000.00

Miscellaneous

Market Cap$3.08 billion
Next Earnings Date3/1/2021 (Confirmed)
OptionableOptionable

MarketRank

Overall MarketRank

1.26 out of 5 stars

Medical Sector

780th out of 1,956 stocks

Biological Products, Except Diagnostic Industry

107th out of 177 stocks

Analyst Opinion: 1.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.6 5 -4 -3 -2 -1 -
$69.79
-0.85 (-1.20 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive NSTG News and Ratings via Email

Sign-up to receive the latest news and ratings for NSTG and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











NanoString Technologies (NASDAQ:NSTG) Frequently Asked Questions

Is NanoString Technologies a buy right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NanoString Technologies in the last twelve months. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" NanoString Technologies stock.
View analyst ratings for NanoString Technologies
or view top-rated stocks.

What stocks does MarketBeat like better than NanoString Technologies?

Wall Street analysts have given NanoString Technologies a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but NanoString Technologies wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is NanoString Technologies' next earnings date?

NanoString Technologies is scheduled to release its next quarterly earnings announcement on Monday, March 1st 2021.
View our earnings forecast for NanoString Technologies
.

How can I listen to NanoString Technologies' earnings call?

NanoString Technologies will be holding an earnings conference call on Monday, March 1st at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were NanoString Technologies' earnings last quarter?

NanoString Technologies, Inc. (NASDAQ:NSTG) issued its quarterly earnings data on Monday, November, 9th. The biotechnology company reported ($0.56) earnings per share for the quarter, beating analysts' consensus estimates of ($0.61) by $0.05. The biotechnology company earned $31.85 million during the quarter, compared to analysts' expectations of $30.13 million. NanoString Technologies had a negative trailing twelve-month return on equity of 68.96% and a negative net margin of 53.47%.
View NanoString Technologies' earnings history
.

How has NanoString Technologies' stock been impacted by COVID-19?

NanoString Technologies' stock was trading at $30.50 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NSTG shares have increased by 128.8% and is now trading at $69.79.
View which stocks have been most impacted by COVID-19
.

What price target have analysts set for NSTG?

5 analysts have issued 1 year price objectives for NanoString Technologies' shares. Their forecasts range from $35.00 to $75.00. On average, they anticipate NanoString Technologies' stock price to reach $55.83 in the next year. This suggests that the stock has a possible downside of 20.0%.
View analysts' price targets for NanoString Technologies
or view top-rated stocks among Wall Street analysts.

Who are NanoString Technologies' key executives?

NanoString Technologies' management team includes the following people:
  • Mr. R. Bradley Gray, CEO, Pres & Director (Age 44, Pay $1.07M)
  • Mr. K. Thomas Bailey M.B.A., Chief Financial Officer (Age 52, Pay $589.26k)
  • Mr. David W. Ghesquiere, Sr. VP of Corp. & Bus. Devel. (Age 54, Pay $557.69k)
  • Mr. J. Chad Brown, Sr. VP of Sales & Marketing (Age 63, Pay $573.07k)
  • Dr. Joseph M. Beechem, Chief Scientific Officer and Sr. VP of R&D (Age 63, Pay $575.41k)
  • Mr. Mark A. Winham, Sr. VP of Operations
  • Mr. Douglas S. Farrell, VP of Investor Relations & Corp. Communications
  • Ms. Kathryn Surace-Smith, Sr. VP of HR & Legal Affairs (Age 62)
  • Dr. Mary Tedd Allen, Sr. VP of Strategic Initiatives (Age 58)
  • Dr. Philippa Webster Ph.D., Sr. Principal Scientist

What is Brad Gray's approval rating as NanoString Technologies' CEO?

36 employees have rated NanoString Technologies CEO Brad Gray on Glassdoor.com. Brad Gray has an approval rating of 65% among NanoString Technologies' employees.

Who are some of NanoString Technologies' key competitors?

What other stocks do shareholders of NanoString Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NanoString Technologies investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Aegean Marine Petroleum Network (ANW), Chipotle Mexican Grill (CMG), Precision Drilling (PD), AutoZone (AZO), Designer Brands (DBI), Bank of the Ozarks (OZRK) and Vista Outdoor (VSTO).

What is NanoString Technologies' stock symbol?

NanoString Technologies trades on the NASDAQ under the ticker symbol "NSTG."

Who are NanoString Technologies' major shareholders?

NanoString Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.10%), Morgan Stanley (8.76%), Orbimed Advisors LLC (3.69%), Sumitomo Mitsui Trust Holdings Inc. (3.02%), Nikko Asset Management Americas Inc. (3.02%) and Federated Hermes Inc. (1.66%). Company insiders that own NanoString Technologies stock include Charles P Waite Jr, Charles P Waite, Jr, David W Ghesquiere, Gregory Norden, J Chad Brown, K Thomas Bailey, Kirk Malloy, Lifesciences Ii LP Clarus, Mary Tedd Allen, R Bradley Gray, Robert Hershberg and William Young.
View institutional ownership trends for NanoString Technologies
.

Which institutional investors are selling NanoString Technologies stock?

NSTG stock was sold by a variety of institutional investors in the last quarter, including FIL Ltd, Sumitomo Mitsui Trust Holdings Inc., Nikko Asset Management Americas Inc., Morgan Stanley, Columbus Circle Investors, Wells Fargo & Company MN, Frontier Capital Management Co. LLC, and RE Advisers Corp. Company insiders that have sold NanoString Technologies company stock in the last year include Charles P Waite Jr, David W Ghesquiere, Gregory Norden, J Chad Brown, K Thomas Bailey, Kirk Malloy, R Bradley Gray, and Robert Hershberg.
View insider buying and selling activity for NanoString Technologies
or view top insider-selling stocks.

Which institutional investors are buying NanoString Technologies stock?

NSTG stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Orbimed Advisors LLC, Alyeska Investment Group L.P., Alyeska Investment Group L.P., Lisanti Capital Growth LLC, WCM Investment Management LLC, WCM Investment Management LLC, and Renaissance Technologies LLC.
View insider buying and selling activity for NanoString Technologies
or or view top insider-buying stocks.

How do I buy shares of NanoString Technologies?

Shares of NSTG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is NanoString Technologies' stock price today?

One share of NSTG stock can currently be purchased for approximately $69.79.

How much money does NanoString Technologies make?

NanoString Technologies has a market capitalization of $3.08 billion and generates $125.57 million in revenue each year. The biotechnology company earns $-40,700,000.00 in net income (profit) each year or ($1.93) on an earnings per share basis.

How many employees does NanoString Technologies have?

NanoString Technologies employs 551 workers across the globe.

What is NanoString Technologies' official website?

The official website for NanoString Technologies is www.nanostring.com.

Where are NanoString Technologies' headquarters?

NanoString Technologies is headquartered at 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109.

How can I contact NanoString Technologies?

NanoString Technologies' mailing address is 530 FAIRVIEW AVENUE NORTH SUITE 2000, SEATTLE WA, 98109. The biotechnology company can be reached via phone at 206-378-6266 or via email at [email protected]


This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.